Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2010
12/22/2010CN101921223A Synthesis method of indole-3-methanol
12/22/2010CN101921164A Synthesis of (1)-beta-elemene, (-)-beta-elemenal, (-)-beta-elemenol, (-)-beta-elemene fluoride and their analogues, intermediates, and composition and uses thereof
12/22/2010CN101920020A New application of human MED19 genes in tumor therapy
12/22/2010CN101920017A Composite for promoting glycyrrhetinic acid to realize percutaneous permeation
12/22/2010CN101920015A Pharmaceutical composition for cancer treatment
12/22/2010CN101920009A Vaccine for preventing and curing tumor
12/22/2010CN101920006A Cyclin Y and use thereof
12/22/2010CN101919991A Drug composition for treating cervical cancer and preparation method thereof
12/22/2010CN101919981A Traditional Chinese medicine for treating cancer
12/22/2010CN101919974A Traditional Chinese medicinal composition for treating glioma and preparation method thereof
12/22/2010CN101919970A Asparagus based preparation for improving human immunity and preventing and treating cardiovascular and cerebrovascular diseases
12/22/2010CN101919967A Traditional Chinese drug for treating esophagus cancer
12/22/2010CN101919917A Chinese patent medicament of cardio-cerebral nephritis-health pills
12/22/2010CN101919908A Magnoliaceae plant extract, preparation method and application thereof
12/22/2010CN101919906A Novel application of salvianolic acid compound as water-soluble component in salvia miltiorrhiza extract
12/22/2010CN101919903A Method for preparing rabdosia rubescens diterpene extract
12/22/2010CN101919888A Carrot extract, preparation method and application thereof
12/22/2010CN101919882A Application of red yeast rice to preparing abdominal aneurvsm medicine
12/22/2010CN101919875A Enteromorpha mushroom polysaccharide compound, preparation method and application as health-care medicament thereof
12/22/2010CN101919867A Method for constructing animal model of Mesocricitus auratus suffering from pancreatic cancer for nuclear magnetic resonance research
12/22/2010CN101919862A Application of benzamide derivative to preparing antitumor drug
12/22/2010CN101919847A Use of HIF alpha stabilizers for enhancing erythropoiesis
12/22/2010CN101919845A Application of matrine compound in preparing anti-prostate tumor drug
12/22/2010CN101919842A Application of phenyl thiophene derivatives in preparing antitumor drugs
12/22/2010CN101919841A Application of eudesmane-type sesquiterpenoids
12/22/2010CN101919839A Usage of mangiferin calcium salt taken as AMPK agonist
12/22/2010CN101919834A Application of 4-[(3-([(2-naphthoxo)acetyl] hydrazono) n-butyryl)amine] benzamide (FD2) in preparing antitumor medicaments
12/22/2010CN101919832A Immunosuppressive agent of advanced higher fatty acid derivative and application thereof
12/22/2010CN101919819A Anti-cancer drug preparation taking Solutol HS 15 as solubilizer
12/22/2010CN101919818A Method for preparing tetrandrine lung-targeted controlled-release microspheres
12/22/2010CN101919815A Flexible cis-platinum vesicle and preparation method thereof
12/22/2010CN101919813A Method for preparing chitosan nanoparticles with recombinant human endostar for injection
12/22/2010CN101919808A Topical fluorouracil vesicle gel and preparation method thereof
12/22/2010CN101497584B Isoquinoline-3-formyl amino acid formyl amino acid benzyl ester, as well as preparation and use thereof
12/22/2010CN101474411B Anti-tumor prodrug using novel amphipathic hyperbranched polyesters as carrier and preparation method
12/22/2010CN101455641B Anti-cancer medicine liposome preparation sensitive to ray
12/22/2010CN101428035B Gemcitabine hydrochloride or gemcitabine composition
12/22/2010CN101416941B Medical composition loaded with nimustine and synergist thereof
12/22/2010CN101401801B Curcumin glutin microsphere and preparation thereof
12/22/2010CN101372471B Novel use of alkyl isourea compound and analogues thereof
12/22/2010CN101366722B Hydrotalcite doxifluridine slow release formulation and preparation method thereof
12/22/2010CN101352448B Use of Liriope muscari Bailey C in pharmacy
12/22/2010CN101336915B Medicine combination with antitumor activity
12/22/2010CN101330912B Pharmaceutical composition of docetaxel, preparation method and purpose
12/22/2010CN101319215B Human tumour specific Ki67 gene promotor
12/22/2010CN101314619B Tumour treatment vaccine CTP37CRM197 immunogen, preparation method and application thereof
12/22/2010CN101293889B Water-soluble arteannuin derivative and preparation method thereof
12/22/2010CN101270158B Target glioma resistant protein, preparation method and application
12/22/2010CN101269110B Radix astragali fermentation liquor for inhibiting cancer cell growth and fermentation method
12/22/2010CN101254301B Preparation of HSP65 recombination protein and use thereof
12/22/2010CN101229227B Water aqua medicine compounds, preparing method and applications thereof
12/22/2010CN101215304B Lactosyl thiourea heterocyclic compound and its synthetic method and application in antineoplastic
12/22/2010CN101181473B Compound maytenfolic splinter
12/22/2010CN101156844B A microemulsion medicinal composition containing Docetaxel for treating knub and its preparation method
12/22/2010CN101129375B Vinorelbine solid lipid nano granule, freeze drying formulated product and method of preparing the same
12/22/2010CN101128461B Imidazo (1, 2-a) pyridine compounds as VEGF-R2 inhibitors
12/22/2010CN101108791B Substituted benzyl ethylene derivant and method of preparing the same and use thereof
12/22/2010CN101092408B Lactone compound of sweetsop connected through amido bond, synthetic method and application
12/22/2010CN101081219B Composition containing taxane genus compound, the method for preparing the same and the use thereof
12/22/2010CN101072779B 2,4 (4,6) pyrimidine derivatives
12/22/2010CN101057908B Heart and brain health dispersion tablet and its preparation method
12/22/2010CN101048406B Novel substituted imidazole derivatives
12/21/2010US7855278 antibodies which induces the death of a cell that expresses Stra6 polypeptide; used to prevent or slow down (lessen) the development, growth, or spread of tumor characterized by the overexpression of a PRO10282 polypeptide; chemotherapy
12/21/2010US7855219 2-Amino-4-(1,3-benzodioxol-5-yl)-6-benzyloxy-3,5-pyridinedicarbonitrile, acting as adenosine-receptor-selective ligands, for the prophylaxis and/or treatment of cardiovascular disorders
12/21/2010US7855216 e.g. 3-(4-Bromo-2-fluoro-phenylamino)-1-methyl-1H-pyrrolo[3,2-c]pyridine-2-carboxylic acid ethyl ester; MEK kinase (Mitogen-Activated protein kinase kinase) inhibitor; anticarcinogenic, antiinflammatory agent; rheumatoid arthritis
12/21/2010US7855214 Autoimmune, inflammatory, proliferative, or hyperproliferative disease or an immunologically-mediated disease; inhibitors of the Tec family of non-receptor tyrosine kinases; compounds are quinazolino[3,2-a]quinazolin-12-ones
12/21/2010US7855203 Indazolyl-substituted pyrroline compounds as kinase inhibitors
12/21/2010US7855199 antitumor agents such as 2-(2-difluoromethyl-4-methoxybenzimidazol-1 -yl)-4-(cis-2,6-dimethylmorpholino)-6-morpholinopyrimidine, used for inhibiting the growth of a human colon cancer cell, a human lung cancer cell, a human breast cancer cell or a human prostate cancer cell
12/21/2010US7855197 Administering Diamino-substituted phenothiazinium compound; antimicrobial photosensitisers effective against Gram negative bacteria, Gram positive bacteria; photodynamic therapy
12/21/2010US7855192 A 2-azabicyclo(16.3.1)docosa-1(21),4,6,10,18-penntaen-9-ylcarbamate derivative; Heat shock protein 90 inhibitors; hyperproliferative disease, breast cancer, ovarian cancer, leukemia, colon cancer, lung cancer
12/21/2010US7855191 Agent having a destructive effect on malignant tumors and method for the production thereof
12/21/2010US7855184 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells and methods of treating ophthalmic and dermatological diseases
12/21/2010US7855075 Methods of controlling proliferation and differentiation of stem and progenitor cells
12/21/2010US7855066 the ions include zinc and cobalt which improve Apo-2 ligand trimer formation and stability; tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
12/21/2010US7855058 Human cyclin-dependent kinase (hPNQALRE)
12/21/2010US7855056 Antibody against tumor specific antigen as target
12/21/2010US7854934 For treatment of cancer, preferably for prevention of recurrence of cancer, and for inducing antibodies in subject by administering glycopeptides
12/21/2010US7854933 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
12/21/2010US7854928 Injecting directly into a tumor; cancer vaccine
12/21/2010US7854717 uses ultrapheresis, refined to remove compounds of less than 120,000 daltons molecular weight, followed by administration of replacement fluid, to stimulate the patient's immune system to attack solid tumors
12/21/2010CA2618466C Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases
12/21/2010CA2577937C Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors
12/21/2010CA2564872C Iap bir domain binding compounds
12/21/2010CA2532067C N-methyle-substituted benzamidazoles
12/21/2010CA2470109C Substituted phenyl naphthalenes as estrogenic agents
12/21/2010CA2460956C Tetrapeptide derivative crystals
12/21/2010CA2444130C Adenine derivatives
12/21/2010CA2441386C Metal substituted non centrosymmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
12/21/2010CA2434337C Combination of probiotics
12/21/2010CA2432137C Crystal forms of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3h-imidazol-4-yl)-methyl]-4-(3-ethynyl-phenyl)-1-methyl-1h-quinolin-2-one, 2,3-dihydroxybutanedioate salts and method of production
12/21/2010CA2426654C 2,4,8-trisubstituted-8h-pyrido[2,3-d}pyrimidin-7-one compounds
12/21/2010CA2423351C Novel arylalkane-sulfonamides
12/21/2010CA2411981C Urokinase inhibitors
12/21/2010CA2408596C New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound
12/21/2010CA2388595C Methods and devices for identifying patterns in biological systems and methods for uses thereof
12/21/2010CA2387182C Lentiviral vectors for the preparation of immunotherapeutical compositions
12/21/2010CA2369895C High affinity inhibitors for target validation and uses thereof
12/21/2010CA2366674C Pharmaceutical compositions comprising erythropoietin for treatment of cancer
12/21/2010CA2362858C Compositions and methods for their preparation from lepidium
12/21/2010CA2329138C Glycoproteins having lipid mobilising properties and therapeutic applications thereof
1 ... 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 ... 2211